| CXSS2500016 | 重组人促卵泡激素注射液 | Recombinant Human Follitropin Alfa | Injection | Biological Products(3.3) | New Drug Application | 2025-01-25 | | Livzon Mabpharm INC;Livzon (GROUP) Pharmaceutical FACTORY | | | view |
| CXSS2500014 | 长效重组人促卵泡激素注射液 | Recombinant Human Follitropin Alfa | Injection | Biological Products(3.2) | New Drug Application | 2025-01-24 | | Beijing SL Pharmaceutical Co Ltd | | | view |
| CXSS2500013 | 长效重组人促卵泡激素注射液 | Recombinant Human Follitropin Alfa | Injection | Biological Products(3.2) | New Drug Application | 2025-01-24 | | Beijing SL Pharmaceutical Co Ltd | | | view |
| JYSB2400246 | 重组人促卵泡激素注射液 | Recombinant Human Follitropin Alfa | Injection | Biological Products | Supplementary Application | 2024-11-29 | | Merck Europe BV;Merck Serono SpA | | | view |
| JYSB2400245 | 重组人促卵泡激素注射液 | Recombinant Human Follitropin Alfa | Injection | Biological Products | Supplementary Application | 2024-11-29 | | Merck Europe BV;Merck Serono SpA | | | view |
| JYSB2400244 | 重组人促卵泡激素注射液 | Recombinant Human Follitropin Alfa | Injection | Biological Products | Supplementary Application | 2024-11-29 | | Merck Europe BV;Merck Serono SpA | | | view |
| CXSL2400754 | 重组人促卵泡激素注射液 | Recombinant Human Follitropin Alfa | Injection | Biological Products(3.3) | New Drug Application | 2024-11-08 | | QILU Pharmaceutical Co Ltd | | | view |
| CXSL2400753 | 重组人促卵泡激素注射液 | Recombinant Human Follitropin Alfa | Injection | Biological Products(3.3) | New Drug Application | 2024-11-08 | | QILU Pharmaceutical Co Ltd | | | view |
| JYSB2400092 | 重组人促卵泡激素注射液 | Recombinant Human Follitropin Alfa | Injection | Biological Products | Supplementary Application | 2024-04-23 | | Merck Europe BV;Merck Serono SpA | | | view |
| JYSB2400090 | 重组人促卵泡激素注射液 | Recombinant Human Follitropin Alfa | Injection | Biological Products | Supplementary Application | 2024-04-23 | | Merck Europe BV;Merck Serono SpA | | | view |
| JYSB2400091 | 重组人促卵泡激素注射液 | Recombinant Human Follitropin Alfa | Injection | Biological Products | Supplementary Application | 2024-04-23 | | Merck Europe BV;Merck Serono SpA | | | view |
| JYSB2400064 | 重组人促卵泡激素注射液 | Recombinant Human Follitropin Alfa | Injection | Biological Products | Supplementary Application | 2024-03-27 | | Lg Chem Ltd | | | view |
| JYSB2400065 | 重组人促卵泡激素注射液 | Recombinant Human Follitropin Alfa | Injection | Biological Products | Supplementary Application | 2024-03-27 | | Lg Chem Ltd | | | view |
| JYSB2400063 | 重组人促卵泡激素注射液 | Recombinant Human Follitropin Alfa | Injection | Biological Products | Supplementary Application | 2024-03-27 | | Lg Chem Ltd | | | view |
| JYSB2400066 | 重组人促卵泡激素注射液 | Recombinant Human Follitropin Alfa | Injection | Biological Products | Supplementary Application | 2024-03-27 | | Lg Chem Ltd | | | view |
| CYSB2400037 | 重组人促卵泡激素注射液 | Recombinant Human Follitropin Alfa | Injection | Biological Products(3.4) | Supplementary Application | 2024-02-08 | | Changchun GeneScience Pharmaceutical Co Ltd | | | view |
| JYSB2400025 | 重组人促卵泡激素注射液 | Recombinant Human Follitropin Alfa | Injection | Biological Products | Supplementary Application | 2024-02-05 | | Merck Europe BV;Merck Serono SpA | | | view |
| JYSB2400026 | 重组人促卵泡激素注射液 | Recombinant Human Follitropin Alfa | Injection | Biological Products | Supplementary Application | 2024-02-05 | | Merck Europe BV;Merck Serono SpA | | | view |
| JYSB2400024 | 重组人促卵泡激素注射液 | Recombinant Human Follitropin Alfa | Injection | Biological Products | Supplementary Application | 2024-02-05 | | Merck Europe BV;Merck Serono SpA | | | view |
| JYSB2400013 | 重组人促卵泡激素注射液 | Recombinant Human Follitropin Alfa | Injection | Biological Products | Supplementary Application | 2024-01-24 | | Merck Europe BV;Merck Serono SpA | | | view |
